DNABERT vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-09-01
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionDNABERTIsomorphic Labs
PricingFree (open-source)Contact-based (partnership model)
Target UserComputational biologists, bioinformaticiansPharma companies, large-scale drug programs
Core TechnologyBERT-based transformer for DNA sequencesAlphaFold-based predictive & generative AI for drug discovery
DeploymentSelf-hosted, open-source code & weightsProprietary, no public API; operates via partnerships
Recent MilestonesNo recent news$600M investment (2025), Series B (2026), collaborations with Novartis & J&J
Best ForGenomic prediction tasks (promoter, TF binding, splice sites)AI-driven drug design & lead optimization at scale

Choose DNABERT if you're a computational biologist needing a free, open-source model for DNA sequence analysis and genomic prediction. Choose Isomorphic Labs if you're a pharma company seeking a deep partnership for AI-driven drug discovery, backed by AlphaFold expertise and significant funding.

DNABERT
DNABERT

Open-source pre-trained transformer for DNA sequence analysis and genomic prediction.

Visit Website
Isomorphic Labs
Isomorphic Labs

AI-native drug discovery partner building on AlphaFold for pharma R&D.

Visit Website
Pricing
Free
Contact Sales
Plans
Popularity
3 views
7.4k views
Skill Level
Intermediate
Advanced
API Available
Platforms
CLI
Categories
🧬 Drug Discovery & Life Sciences
🧬 Drug Discovery & Life Sciences
Features
Pre-trained on human reference genome (hg38)
K-mer based tokenization (3, 4, 5, 6-mers)
Fine-tuning for genomic prediction tasks
Promoter prediction
Transcription factor binding site prediction
Splice site detection
Masked language modeling pre-training
Bidirectional contextual representations for DNA
Open-source code and pretrained weights
Compatibility with PyTorch and Hugging Face Transformers
Customizable model architecture
Evaluation scripts for benchmark datasets
Utilities for DNA sequence preprocessing
Supports transfer learning for genomics
Community-driven development on GitHub
Drug Design Engine for generative molecule design
Predictive and generative AI models for drug discovery
AlphaFold-based structure prediction
Simulation of drug behavior and performance
End-to-end research collaborations from target to lead
Digital biology simulation at scale
Bioresilience framework for pandemic preparedness
Collaborative R&D with major pharma partners
Target identification and lead optimization support
US operations since 2025

What real users say: DNABERT vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

DNABERT

33 mentions across 2 sources · 45% positive — mixed

Bluesky, GitHub

What users praise

  • Strong performance on benchmark genomic tasks like promoter and splice site prediction.
  • DNABERT-2 competes with RNA-specific models despite being trained only on DNA.
  • Pre-trained on human reference genome, reducing need for task-specific feature engineering.
  • Open-source with pretrained weights available for download and fine-tuning.

What frustrates them

  • Motif analysis step is broken, preventing biological insight extraction.
  • Frequent installation and runtime bugs like segmentation faults and tokenizer errors.
  • Poor performance when pre-trained on small or non-human datasets.
  • High number of open issues (73) suggests maintenance challenges.

Researched Jul 16, 2026

Isomorphic Labs

46 mentions across 3 sources · 73% positive

Hacker News, YouTube, Lemmy

What users praise

  • Backed by DeepMind's AlphaFold legacy and Nobel-winning science.
  • Massive pharma partnerships: Novartis, J&J, Eli Lilly.
  • Drug Design Engine (July 2026) moves beyond structure prediction.
  • Generative AI for molecule design, simulating drug behavior.

What frustrates them

  • Not a self-serve tool; partnership-only model limits access.
  • CASP16 shows no clear advantage over older prediction methods.
  • Clinical outcomes unproven; no approved drugs yet.
  • Returns tied to performance milestones, uncertain timeline.

Researched Aug 26, 2026

Who should pick which

  • Academic researcher studying transcription factors
    Pick: DNABERT

    Free, pre-trained model for DNA sequence analysis with specific capabilities for transcription factor binding site prediction.

  • Pharma company seeking to accelerate lead optimization
    Pick: Isomorphic Labs

    Isomorphic Labs provides AI-driven drug design and predictive modeling through partnerships, backed by AlphaFold and significant funding.

  • Bioinformatician developing a genome annotation pipeline
    Pick: DNABERT

    Open-source and customizable, DNABERT can be integrated into computational workflows for promoter and splice site detection.

  • Large-scale drug development consortium
    Pick: Isomorphic Labs

    Partnership model allows collaborative large-scale projects; recent collaborations with Novartis and J&J demonstrate this capability.

Frequently Asked Questions

DNABERT vs Isomorphic Labs: which should you choose?

Choose DNABERT if you're a computational biologist needing a free, open-source model for DNA sequence analysis and genomic prediction. Choose Isomorphic Labs if you're a pharma company seeking a deep partnership for AI-driven drug discovery, backed by AlphaFold expertise and significant funding.

Can I use DNABERT for drug discovery?

DNABERT is designed for DNA sequence analysis (e.g., promoter prediction) rather than protein-ligand interactions, so it's not directly suited for drug discovery tasks.

Is Isomorphic Labs available for individual researchers?

No, Isomorphic Labs operates exclusively through partnerships with pharmaceutical companies and does not offer direct access to individuals or small teams.

Does Isomorphic Labs provide a software API?

No, Isomorphic Labs' tools are proprietary and not publicly available as an API; they are used internally within their drug design engine.

What hardware do I need to run DNABERT?

DNABERT requires a compatible GPU (e.g., NVIDIA with CUDA) for efficient training and inference; details are in the repository documentation.

How does Isomorphic Labs' partnership model work?

Isomorphic Labs collaborates with pharma partners like Novartis and J&J on large-scale drug development programs, combining their AI platform with partner expertise.

Can DNABERT predict protein structure?

No, DNABERT is focused on DNA sequences, not protein structures. For protein structure prediction, tools like AlphaFold would be appropriate.

Has Isomorphic Labs published any results?

The provided data does not mention published results; the company's work is typically through confidential partnerships.

Is DNABERT suitable for real-time analysis?

DNABERT is not optimized for real-time analysis; it requires fine-tuning and inference on pre-processed sequences, making it better suited for batch analysis.

More DNABERT or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 7, 2026